Boosters increase protection against death from Omicron in over-50s to 95% - UKHSA

COVID-19 boosters increase protection against death from the Omicron variant to 95% in people aged 50 or over, the UK Health Security Agency said on Thursday.

Covıd, Gen

1/27/2022 8:00:00 PM

COVID -19 boosters increase protection against death from the Omicron variant to 95% in people aged 50 or over, the UK Health Security Agency said on Thursday.

COVID -19 boosters increase protection against death from the Omicron variant to 95% in people aged 50 or over, the UK Health Security Agency said on Thursday.

UKHSA added that data continued to show high levels of protection against hospitalisation from the booster. Effectiveness against hospitalisation was around 90% for the Pfizer-BioNTech shot, , dropping to 75% 10-14 weeks after the booster.Register now for FREE unlimited access to Reuters.com

Register(MRNA.O), effectiveness against hospitalisation was 90-95% up to 9 weeks after the booster."The evidence is clear – the vaccine helps to protect us all against the effects of COVID-19 and the booster is offering high levels of protection from hospitalisation and death in the most vulnerable members of our society," said Dr Mary Ramsay, Head of Immunisation at UKHSA.

Read more: Reuters Science News »

Death from omicron? At this point you can say that this 3rd jab confers immortality.

Moderna starts trial of an omicron-specific COVID-19 vaccineBoosters of the original still protect against omicron. There's already a new variant so... About damn time Eeeevryboooday! Shots shots shots

Moderna begins testing omicron-specific COVID-19 vaccine in adultsIt’s not clear whether global health authorities will order a change to the vaccine recipe in the wake of the hugely contagious omicron variant, since the original vaccines still offer good protection.

Moderna Booster May Wane After 6 Months, Company SaysThe Moderna vaccine and booster don't protect against Omicron as well as they do against the original SARS-CoV-2

Moderna starts trial on omicron-specific Covid booster in adultsModerna starts its clinical trial using an omicron-specific booster vaccine. Pfizer has also started testing a vaccine for omicron.

NY Daily News - We are currently unavailable in your region

Moderna starts clinical trial of booster shot targeting omicron Covid variantThe first participant in the trial has already received a dose of the omicron-specific booster shot, according to Moderna. What’s the point? Omicron gonna have run it’s course by the time it’s done… JAB ME HARDER DADDY. MORE!!!!!